These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7499096)

  • 1. Studies of adenovirus-induced eye disease in the rabbit model.
    Trousdale MD; Nóbrega R; Wood RL; Stevenson D; dos Santos PM; Klein D; McDonnell PJ
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2740-8. PubMed ID: 7499096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus infection of the cornea causes histopathologic changes in the lacrimal gland.
    Wood RL; Trousdale MD; Stevenson D; Azzarolo AM; Mircheff AK
    Curr Eye Res; 1997 May; 16(5):459-66. PubMed ID: 9154384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple adenoviral serotypes demonstrate host range extension in the New Zealand rabbit ocular model.
    Romanowski EG; Araullo-Cruz T; Gordon YJ
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):532-6. PubMed ID: 9501863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ocular model of adenovirus type 5 infection in the NZ rabbit.
    Gordon YJ; Romanowski E; Araullo-Cruz T
    Invest Ophthalmol Vis Sci; 1992 Mar; 33(3):574-80. PubMed ID: 1312070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
    Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
    Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adenovirus type 5 early region 3 in the pathogenesis of ocular disease and cell culture infection.
    Trousdale MD; Nóbrega R; Stevenson D; Nakamura T; dos Santos PM; Labree L; McDonnell PJ
    Cornea; 1995 May; 14(3):280-9. PubMed ID: 7600812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.
    de Oliveira CB; Stevenson D; LaBree L; McDonnell PJ; Trousdale MD
    Antiviral Res; 1996 Jul; 31(3):165-72. PubMed ID: 8811201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
    Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.
    Romanowski EG; Gordon YJ; Araullo-Cruz T; Yates KA; Kinchington PR
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1812-5. PubMed ID: 11431446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent herpes simplex after corneal transplantation in rats.
    Nicholls SM; Shimeld C; Easty DL; Hill TJ
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):425-35. PubMed ID: 8603848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of conjunctival glutathione secretion and ion transport by oxidative stress in an adenovirus type 5 ocular infection model of pigmented rabbits.
    Kannan R; Gukasyan HJ; Zhang W; Trousdale MD; Kim KJ; Lee VH
    Free Radic Biol Med; 2004 Jul; 37(2):229-38. PubMed ID: 15203194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
    Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
    Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
    Romanowski EG; Gordon YJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus keratitis: a role for interleukin-8.
    Chodosh J; Astley RA; Butler MG; Kennedy RC
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):783-9. PubMed ID: 10711694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
    Gordon YJ; Romanowski EG; Araullo-Cruz T
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility class II expression in the normal canine cornea and in canine chronic superficial keratitis.
    Williams DL
    Vet Ophthalmol; 2005; 8(6):395-400. PubMed ID: 16359362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.